Biotech & Health Tech
Merck KGaA lands FDA nod for joint tumor drug it licensed from Abbisko
Merck KGaA said Tuesday that the drug it licensed from a China-based biotech has secured FDA approval for rare noncancerous tumors that impact the joints. The German conglomerate got the
Merck KGaA said Tuesday that the drug it licensed from a China-based biotech has secured FDA approval for rare noncancerous tumors that impact the joints. The German conglomerate got the
This is a summary of the story. Read the full article at Endpoints News (Biopharma) ↗